- Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
-
Hong J, Kyung SY, Lee SP, Park JW, Jung SH, Lee JI, Park SH, Sym SJ, Park J, Cho EK, Shin DB, Lee JH
- KMID: 1776611
- Korean J Intern Med.
- 2010 Sep;25(3):294-300.
- doi: 10.3904/kjim.2010.25.3.294
BACKGROUND/AIMS: The efficacy and safety of pemetrexed, gefitinib, and erlotinib administration in previously treated patients with non-small cell lung cancer (NSCLC) were compared. METHODS: The study patients met the following... -
- CITED
-
- Close
- SHARE
-
- Close
